<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Neurosci.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fncel.2025.1754379</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Celebrating the year of Ramon y Cajal: cellular biology of the retina</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cuenca</surname> <given-names>Nicol&#x000E1;s</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/172749"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Canto-Soler</surname> <given-names>M. Valeria</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1124095"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Becerra</surname> <given-names>S. Patricia</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1245586"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Physiology, Genetics and Microbiology, University of Alicante</institution>, <city>Alicante</city>, <country country="es">Spain</country></aff>
<aff id="aff2"><label>2</label><institution>CellSight Ocular Stem Cell and Regeneration Research Program, Department of Ophthalmology, Sue Anschutz-Rodgers Eye Center, University of Colorado</institution>, <city>Aurora, CO</city>, <country country="us">United States</country></aff>
<aff id="aff3"><label>3</label><institution>Section of Protein Structure and Function, National Eye Institute, National Institutes of Health</institution>, <city>Bethesda, MD</city>, <country country="us">United States</country></aff>
<author-notes>
<corresp id="c001"><label>&#x0002A;</label>Correspondence: Nicol&#x000E1;s Cuenca, <email xlink:href="mailto:cuenca@ua.es">cuenca@ua.es</email>; M. Valeria Canto-Soler, <email xlink:href="mailto:valeria.canto-soler@cuanschutz.edu">valeria.canto-soler@cuanschutz.edu</email>; S. Patricia Becerra, <email xlink:href="mailto:becerras@nei.nih.gov">becerras@nei.nih.gov</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-06">
<day>06</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>19</volume>
<elocation-id>1754379</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2026 Cuenca, Canto-Soler and Becerra.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Cuenca, Canto-Soler and Becerra</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-06">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/49139/celebrating-the-year-of-ramon-y-cajal-cellular-biology-of-the-retina" ext-link-type="uri">Editorial on the Research Topic <article-title>Celebrating the year of Ramon y Cajal: cellular biology of the retina</article-title></related-article>
<kwd-group>
<kwd>eye development</kwd>
<kwd>ocular biology</kwd>
<kwd>retina physiology</kwd>
<kwd>retina therapeutic strategies</kwd>
<kwd>retinal cell biology</kwd>
<kwd>retinal degenerative diseases</kwd>
<kwd>retinal development</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported in part by grants from the Ministerio de Ciencia (FEDER-PID2019-106230RB-I00) and Generalitat Valenciana (IDIFEDER/2017/064, PROMETEO/2021/024) and acci&#x000F3;n Marie Curie ITN, HORIZON-MSCA-2021-DN-01-01 RETORNA (NC); The Doni Solich Family Chair in Ocular Stem Cell Research and an unrestricted grant to the Department of Ophthalmology, University of Colorado from Research to Prevent Blindness (MVC-S). This research was also supported in part by the Intramural Research Program of the National Institutes of Health (NIH), The National Eye Institute. The contributions of the NIH author (SB) were made as part of their official duties as NIH federal employees, are in compliance with agency policy requirements, and are considered Works of the United States Government. However, the findings and conclusions presented in this paper are those of the author and do not necessarily reflect the views of the NIH or the U.S. Department of Health and Human Services.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="9"/>
<page-count count="4"/>
<word-count count="3036"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cellular Neurophysiology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>The figure of Santiago Ram&#x000F3;n y Cajal (1852&#x02013;1934) and his groundbreaking work on the organization of the nervous system and the Neuron Theory are widely recognized. His monumental contributions rightly earned him the title of the founder of modern neuroscience. Alongside Camillo Golgi, Cajal was awarded the Nobel Prize in Physiology or Medicine in 1906 for their pioneering studies on the structure of the nervous system. While Golgi adhered to the reticular theory, Cajal used Golgi&#x00027;s staining method to reach a profoundly different conclusion, one that culminated in the neuron doctrine, which became a cornerstone of neuroscience.</p>
<p>Despite his extensive contributions, Cajal&#x00027;s studies on the structure and neuronal types of the retina remain relatively overlooked. His seminal work, &#x0201C;<italic>La r&#x000E9;tine des vert&#x000E9;br&#x000E9;s</italic>&#x0201D; wrote in French (<xref ref-type="bibr" rid="B4">Ram&#x000F3;n y Cajal, 1892</xref>), translated in English (<xref ref-type="bibr" rid="B5">Ram&#x000F3;n y Cajal, 1972</xref>) and Spanish (<xref ref-type="bibr" rid="B6">Ram&#x000F3;n y Cajal, 2021</xref>), is among his most remarkable achievements. Cajal recognized the retina as an ideal model for uncovering the characteristics of nerve cells that could be generalized to the entire central nervous system. His meticulous investigations into the structural organization of the retina, combined with his visionary predictions about its functions, laid the foundation for the neuroanatomy, neurophysiology, and neuropathology of this critical sensory organ. The general organizational framework of the retina proposed by Cajal remains fundamentally valid, with many aspects of his work continuing to hold relevance today. His detailed descriptions of retinal cell types and their intricate interconnections, observed across various species, rank among the most comprehensive studies ever conducted. In his memoirs, Cajal expressed deep fondness for studying the retina, calling it the &#x0201C;oldest and most steadfast&#x0201D; of his scientific passions.</p>
<p>Cajal&#x00027;s contributions to retinal research have shaped our understanding of the nervous system, particularly the retina. He meticulously described and classified various retinal cells, including photoreceptors, bipolar cells, amacrine cells, and ganglion cells, across multiple vertebrate species. His studies of the sublaminae of the inner plexiform layer revealed the organizational complexity of retinal nerve cells and their roles in visual signal processing. His discovery of centrifugal fibers connecting to amacrine cells underscored the retina&#x00027;s intricate network and interconnectivity. Cajal also identified cellular convergence circuits essential for visual information processing and described interplexiform cells, which link different retinal layers to facilitate efficient visual integration.</p>
<p>Cajal&#x00027;s work extended to M&#x000FC;ller cells, which he demonstrated to provide structural support, protection, and ionic balance within the retina. Additionally, he offered critical insights into retinal histogenesis during embryonic development, elucidating how retinal cells form and organize. His detailed description of the specialized structure of the fovea deepened our understanding of high-resolution vision. Finally, Cajal proposed a chemotactic theory of neural connection formation, suggesting that chemical signals guide nerve cells during development.</p>
<p>Cajal&#x00027;s pioneering research on the retina remains a cornerstone of retinal studies and continues to influence broader neuroanatomical and neurophysiological research. His legacy as a visionary scientist endures, with his insights remaining as relevant and inspiring as ever in the field of neuroscience.</p>
<p>This Research Topic pays tribute to Santiago Ram&#x000F3;n y Cajal in celebration of the 170th anniversary of his birth by collecting recent advances in the study of retinal cellular biology and methods applied to better understand this complex system. This Research Topic includes eight original research articles, one brief research report, one perspective, and four review articles. These articles encompass various aspects of ocular biology, including molecular pathways that regulate eye and retina development, mechanisms involved in retinal disease, and potential therapeutic strategies. Importantly, these studies are conducted using a range of relevant systems, including rodents, zebrafish, and human samples, as well as emerging models such as human retinal organoids and the Mongolian gerbil.</p>
<p>Retinal neurodegenerative diseases such as age-related macular degeneration, glaucoma, diabetic retinopathy, and retinitis pigmentosa have distinct etiologies but share common cellular and molecular responses to injury, including inflammation, oxidative stress, and apoptosis (<xref ref-type="bibr" rid="B2">Cuenca et al., 2014</xref>). This Research Topic includes three review articles that focus on the mechanisms underlying these conditions.</p>
<p>Glaucoma is a multifactorial disease characterized by the degeneration of retinal ganglion cells and axonal loss. In this context, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1354569">Fern&#x000E1;ndez-Albarral et al.</ext-link> review the molecular mechanisms that contribute to its development, including mitochondrial dysfunction, oxidative stress, vascular dysregulation, and neuroinflammation, all factors that may be exacerbated by aging. The authors also address the central role of glial cells (microglia, astrocytes, and M&#x000FC;ller cells), whose activation may initially be protective, but when sustained, contributes to neurodegeneration by inducing a pro-inflammatory state, as well as the influence of genetic factors and microRNAs, suggesting that modulating the immune response and glial activation are promising approaches for treating the disease.</p>
<p>The study from <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1343544">Bighinati et al.</ext-link> reviews the molecular mechanisms underlying hereditary photoreceptor degeneration, specifically in the context of retinitis pigmentosa. It explores various cell death pathways, such as oxidative stress, inflammation, elevated cGMP levels, calcium imbalance, and endoplasmic reticulum stress caused by misfolded proteins like mutant rhodopsin. The authors detail how each of these factors contributes to disease progression and, crucially, discuss both preclinical and clinical therapeutic approaches targeting these common pathways to preserve visual function and photoreceptor survival, with a focus on gene-agnostic strategies.</p>
<p>Syntaxins are a family of proteins essential for membrane fusion events, specifically within the retina. While syntaxins are known to play key roles in neurotransmitter release and protein trafficking, their specific functions in the retina have been less well-studied. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1380064">Tebbe et al.</ext-link> present a thorough review of the distribution and role of different syntaxins, including STX1, STX2, STX3, and STX4, within retinal layers, their involvement in synaptic transmission in photoreceptor and horizontal cells, and in the trafficking of critical proteins. The study also highlights an emerging association between mutations in syntaxins, particularly STX3, and retinal diseases such as early-onset severe retinal dystrophy, underscoring the importance of these proteins for photoreceptor cell health and survival.</p>
<p>In addition to these review articles, two original research studies further address mechanisms involved in retinal degenerative conditions.</p>
<p>Diabetic retinopathy is a metabolic disorder characterized by molecular and cellular alterations that affect both vascular and neuronal components of the retina, ultimately leading to blindness (<xref ref-type="bibr" rid="B1">Albertos-Arranz et al., 2025</xref>). The study by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1441924">Nam et al.</ext-link> reveals the therapeutic potential of peptain-1 in preventing retinal damage, with a focus on capillary degeneration and neuroinflammation induced by ischemia/reperfusion (I/R) in mice. Their study demonstrates that peptain-1 can block apoptosis of human retinal endothelial cells, a key pathological feature of diabetic retinopathy. Moreover, administration of peptain-1 protects retinal capillaries from I/R-induced damage and attenuates microglial activation and pro-inflammatory cytokine levels in the retina, supporting its potential as a novel treatment for the early stages of ischemic retinal diseases.</p>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1442079">Taskintuna et al.</ext-link> address another emerging factor influencing retinal degeneration by exploring how sex-specific differences affect retina and the retinal pigment epithelium function, especially in the context of aging and suppression of the <italic>Pgc-1</italic>&#x003B1; gene in mice. Their findings show that <italic>Pgc-1</italic>&#x003B1; inhibition leads to a sex-dependent decline in RPE and retinal function, with females exhibiting greater susceptibility to age-related deterioration. The study further reveals that <italic>Pgc-1</italic>&#x003B1; differentially regulates genes involved in antioxidant defense and mitochondrial dynamics in males and females, suggesting that distinct mechanisms of oxidative stress management and mitochondrial function may underlie these disparities. These insights offer promising directions for the development of sex-specific treatments for age-related macular degeneration.</p>
<p>This Research Topic also brings together five studies that illuminate key mechanisms guiding retinal development and their disruption in disease.</p>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1474010">Hofstetter et al.</ext-link> reveal that the Rho GTPase <italic>Cdc42</italic> is essential for optic cup morphogenesis in mice. Loss of <italic>Cdc42</italic> disrupts polarity, cytoskeletal organization, and progenitor proliferation, leading to microphthalmia and coloboma, highlighting its critical role in early eye formation.</p>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1409405">Kar et al.</ext-link> use serial electron microscopy to uncover a novel population of &#x0201C;inner&#x0201D; M&#x000FC;ller glia in the fovea of a human born preterm. These glial cells, structurally distinct from classical M&#x000FC;ller cells, may reflect adaptations to disrupted neuronal migration during development.</p>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1343745">Dalmaso et al.</ext-link> show that deletion of the platelet-activating factor receptor (PAFR) alters post-natal retinal development in mice, increasing progenitor proliferation while impairing neuronal differentiation and synaptic transmission. Their findings identify PAFR as a key regulator of neurogenic balance and circuit maturation.</p>
<p>The study by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2023.1214084">Farre et al.</ext-link> leverages the similarities between the zebrafish retina and the human retina to deepen our understanding of transcriptional heterogeneity in cones that express tandemly replicated opsins and the mechanisms regulating such differential expression. Results from this study suggest that multiple genes within the cones expressing tandemly replicated opsins are non-stochastically regulated, and that multiple signals likely control the transcriptional differences between cone subtypes. These findings contribute to a deeper understanding of the mechanisms that regulate the development of retinal cone subtypes.</p>
<p>Finally, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1347436">Zheng and Chen</ext-link> review 25 years of research on the transcription factor <italic>CRX</italic>, central to photoreceptor gene regulation. They highlight distinct disease mechanisms linked to <italic>CRX</italic> variants and discuss emerging systems biology tools that promise to inform precision therapies.</p>
<p>Together, these contributions underscore the importance of cytoskeletal dynamics, glial specialization, lipid signaling, and transcriptional control in shaping retinal architecture and function.</p>
<p>Current animal models continue to provide invaluable insights into the field of retinal biology; however, their transferability to human retinal biology presents significant limitations due to differences between the human retina and these models. Thus, the development and validation of new human-relevant models to study the mechanisms regulating retinal function in both normal and diseased conditions remain essential.</p>
<p>Contributing to this important effort, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1339282">G&#x000FC;nter et al.</ext-link> report the characterization of a diurnal rodent, the Mongolian gerbil (<italic>Meriones unguiculatus</italic>) (MG), which features a cone-rich retina and a macula-like specialized region. The study focuses on evaluating the MG&#x00027;s cone system functionality using full-field electroretinography (ERG), together with a morphological assessment of the retina and macula-like region via angiography, optical coherence tomography (OCT), and immunohistochemistry. The authors conclude that the MG retina exhibits features similar to those observed in the human retina, thereby providing a suitable model for investigating cone system physiology, pathophysiology, and potentially testing novel therapeutic strategies.</p>
<p>Importantly, human retinal organoids are emerging as powerful, human-relevant models that can recreate, to a certain extent, the cellular composition and organization of the native retina, while providing precise temporal resolution and control over environmental conditions (<xref ref-type="bibr" rid="B7">Vergara et al., 2024</xref>). An important consideration, however, is the inherent variability of this <italic>in vitro</italic> system and its implications for research outcomes and their interpretation.</p>
<p>Within this context, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2023.1166641">Carido et al.</ext-link> assessed the reproducibility, efficiency, and variance of a previously published protocol for generating human retinal organoids, known as the CYST protocol (<xref ref-type="bibr" rid="B9">Zhu et al., 2013</xref>; <xref ref-type="bibr" rid="B3">Lowe et al., 2016</xref>; <xref ref-type="bibr" rid="B8">Volkner et al., 2022</xref>). The study evaluated organoid development, efficiency, and reproducibility, including major retinal cell type composition and its variance across seven hiPSC lines derived by different methods and from various cell sources. Furthermore, the study proposed a potential strategy for systematically evaluating different organoid protocols in a side-by-side comparison. Another important consideration for using retinal organoids for disease modeling is the ability of the <italic>in vitro</italic> system to recapitulate disease hallmarks observed in human patients.</p>
<p>The study conducted by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2024.1340448">James et al.</ext-link> reports the development and characterization of a novel human retinal organoid (RO) model derived from induced pluripotent stem cells (iPSCs) from patients with familial Alzheimer&#x00027;s disease (AD). Notably, AD pathology is found not only in the brain but also in the retinas of AD patients, hence, retinal features of AD are being evaluated as potential biomarkers for disease diagnosis and the evaluation of disease progression. Importantly, this study demonstrated that AD-retinal organoids recapitulate the primary histopathological hallmarks of AD, offering a novel tool for drug screening, biomarker discovery, and pathophysiological studies.</p>
<p>Finally, in a Perspective article, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fncel.2023.1281786">Tsukamoto</ext-link> presents an interesting example of the potential synergy between neuroscience and connectome via artificial intelligence. Specifically, the author discusses the application of convolutional neural network (CNN), a machine learning algorithm robust for classifying neuron borderlines on electron micrograph images for automated connectomic analysis, to study the primary rod signal pathway in mouse and macaque retinas with special reference to electrical synapses.</p>
<p>Altogether, this Research Topic reflects the substantial progress made in retinal research since Cajal&#x00027;s pioneering work. The studies presented here advance our understanding of retinal development, cellular physiology, and degenerative mechanisms, while underscoring the growing importance of human-relevant models. In doing so, they not only honor Cajal&#x00027;s foundational contributions but also highlight emerging directions that will inform future efforts to uncover disease mechanisms and develop effective therapies to preserve vision.</p>
</body>
<back>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>NC: Writing &#x02013; review &#x00026; editing, Funding acquisition, Writing &#x02013; original draft. MVC-S: Writing &#x02013; original draft, Funding acquisition, Writing &#x02013; review &#x00026; editing. SPB: Writing &#x02013; review &#x00026; editing, Writing &#x02013; original draft, Funding acquisition.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author NC declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s3">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albertos-Arranz</surname> <given-names>H.</given-names></name> <name><surname>Martinez-Gil</surname> <given-names>N.</given-names></name> <name><surname>Sanchez-Saez</surname> <given-names>X.</given-names></name> <name><surname>Molina-Martin</surname> <given-names>J. C.</given-names></name> <name><surname>Lax</surname> <given-names>P.</given-names></name> <name><surname>Cuenca</surname> <given-names>N.</given-names></name></person-group> (<year>2025</year>). <article-title>Neuronal degeneration and glial activation in the absence of vascular changes in human retinas of patients with diabetes</article-title>. <source>Invest. Ophthalmol. Vis. Sci.</source> <volume>66</volume>:<fpage>53</fpage>. doi: <pub-id pub-id-type="doi">10.1167/iovs.66.3.53</pub-id><pub-id pub-id-type="pmid">40131295</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuenca</surname> <given-names>N.</given-names></name> <name><surname>Fernandez-Sanchez</surname> <given-names>L.</given-names></name> <name><surname>Campello</surname> <given-names>L.</given-names></name> <name><surname>Maneu</surname> <given-names>V.</given-names></name> <name><surname>De La Villa</surname> <given-names>P.</given-names></name> <name><surname>Lax</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases</article-title>. <source>Prog. Retin. Eye Res.</source> <volume>43</volume>, <fpage>17</fpage>&#x02013;<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.preteyeres.2014.07.001</pub-id><pub-id pub-id-type="pmid">25038518</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname> <given-names>A.</given-names></name> <name><surname>Harris</surname> <given-names>R.</given-names></name> <name><surname>Bhansali</surname> <given-names>P.</given-names></name> <name><surname>Cvekl</surname> <given-names>A.</given-names></name> <name><surname>Liu</surname> <given-names>W.</given-names></name></person-group> (<year>2016</year>). <article-title>Intercellular adhesion-dependent cell survival and ROCK-regulated actomyosin-driven forces mediate self-formation of a retinal organoid</article-title>. <source>Stem Cell Rep.</source> <volume>6</volume>, <fpage>743</fpage>&#x02013;<lpage>756</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.stemcr.2016.03.011</pub-id><pub-id pub-id-type="pmid">27132890</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000F3;n y Cajal</surname> <given-names>S.</given-names></name></person-group> (<year>1892</year>). <article-title>La r&#x000E9;tine des vert&#x000E9;br&#x000E9;s</article-title>. <source>Cellule</source> <volume>9</volume>, <fpage>119</fpage>&#x02013;<lpage>255</lpage>.</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ram&#x000F3;n y Cajal</surname> <given-names>S.</given-names></name></person-group> (<year>1972</year>). <source>The Structure of the Retina</source>. Translated and compiled by S. A. Thorpe &#x00026; M. Glickstein. <publisher-loc>Springfield, IL</publisher-loc>: <publisher-name>Charles C</publisher-name>. Thomas.</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000F3;n y Cajal</surname> <given-names>S.</given-names></name></person-group> (<year>2021</year>). <source>La retina de los vertebrados</source>, eds N. Cuenca and P. de la Villa. Madrid: Consejo Superior de Investigaciones Cient&#x000ED;ficas.</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vergara</surname> <given-names>M. N.</given-names></name> <name><surname>Jones</surname> <given-names>K.</given-names></name> <name><surname>James</surname> <given-names>E.</given-names></name> <name><surname>Canto-Soler</surname> <given-names>M. V.</given-names></name></person-group> (<year>2024</year>). <article-title>&#x0201C;Retinal organoids: an emerging model to study human retinal development,&#x0201D;</article-title> in <source>Encyclopedia of the Eye</source>, ed. P. A. D&#x00027;Amore (Elsevier Academic Press), <fpage>757</fpage>&#x02013;<lpage>764</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-443-13820-1.00138-9</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkner</surname> <given-names>M.</given-names></name> <name><surname>Wagner</surname> <given-names>F.</given-names></name> <name><surname>Steinheuer</surname> <given-names>L. M.</given-names></name> <name><surname>Carido</surname> <given-names>M.</given-names></name> <name><surname>Kurth</surname> <given-names>T.</given-names></name> <name><surname>Yazbeck</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>HBEGF-TNF induce a complex outer retinal pathology with photoreceptor cell extrusion in human organoids</article-title>. <source>Nat. Commun.</source> <volume>13</volume>:<fpage>6183</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-33848-y</pub-id><pub-id pub-id-type="pmid">36261438</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Carido</surname> <given-names>M.</given-names></name> <name><surname>Meinhardt</surname> <given-names>A.</given-names></name> <name><surname>Kurth</surname> <given-names>T.</given-names></name> <name><surname>Karl</surname> <given-names>M. O.</given-names></name> <name><surname>Ader</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Three-dimensional neuroepithelial culture from human embryonic stem cells and its use for quantitative conversion to retinal pigment epithelium</article-title>. <source>PLoS ONE</source> <volume>8</volume>:<fpage>e54552</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0054552</pub-id><pub-id pub-id-type="pmid">23358448</pub-id></mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited and reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1846/overview">Arianna Maffei</ext-link>, Stony Brook University, United States</p>
</fn>
</fn-group>
</back>
</article>